Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3112 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 16 17 18 ... 30 31 32  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Univ Jena–ACD/Labs: cheminformatics, 201806 supply ACD/Spectrus Processor + ACD/NMR Workbook Suite + ACD/MS Workbook Suite 2018-06-12
Univ Jena–Bruker: mass spectrometer, 201806 supply existent 2018-06-12
Univ Jena–Shimadzu: mass spectrometer, 201806 supply existent 2018-06-12
Univ Jena–Thermo Fisher: mass spectrometer, 201806 supply existent 2018-06-12
RSP Systems–SEVERAL: investment, 201806 financing round Series B first closing €6.5m incl family offices + private investors 2018-06-11
Roche–Microbiotica: microbiomics, 201806– collab multi-year up to $534m r+d + commerc of markers + targets + treatments for IBD w Genentech 2018-06-06
Roivant–Oxford BioMedica: Parkinson’s gene therapy, 201806– license ww excl to OXB-102 $30m upfront + $812.5m milestones to Axovant Sciences 2018-06-06
Gilead–Hookipa: therapeutic vaccine technology, 201806– collab + license $10m upfront r+d immunotherapies against HIV + HBV 2018-06-05
Arvinas–Bayer: investment, 201806 founding agricultural 50/50 joint venture w $55m committed funding from Bayer + techn + IP from Arvinas 2018-06-04
Bayer–Arvinas: PROTAC technology, 201806– collab agricultural 50/50 joint venture w $55m committed funding from Bayer + techn + IP from Arvinas 2018-06-04
Secarna–MC Services: public relations, 201806 service existent by MC Services 2018-06-04
Sierra Sensors–Bruker: investment, 201806 acquisition €na of Sierra Sensors GmbH by Bruker 2018-06-04
Univ Birmingham–Thermo Fisher: mass spectrometer, 201806 supply existent early customer Orbitrap ID-X Tribrid MS system at PCB 2018-06-04
Univ Greifswald–Bruker: NMR spectrometer, 201806 supply installation of AVANCE IVDr at Greifswald Univ Hospital) 2018-06-01
Arix Bioscience–Evotec: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutchinson Cancer Center 2018-05-31
Arix Bioscience–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Evotec 2018-05-31
Evotec–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Arix Bioscience 2018-05-31
Qiagen–Freenome: molecular companion diagnostics, 201805– collab co-marketing of CDx solutions for immuno-oncology 2018-05-31
TxCell–Lonza: cell therapy contract manufacturing, 201805– supply of TX200 for clinical studies by Lonza production site in Geleen (NL) 2018-05-31
Univ Tübingen–ERS Genomics: CRISPR technology, 201804– license €na to NMI + NMI TT Pharmaservices to expand custom cell-based research services 2018-05-31
F-Star–Denali Therapeutics: investment, 201805 acquisition of F-Star Gamma Ltd via early exercise of option for asset-centric vehicle 2018-05-30
Five Prime–Roche: companion diagnostics, 201805– collab €na to develop IHC CDx assays for two cancer antibody candidates 2018-05-30
Ultra Scientific–Agilent: investment, 201805– acquisition of all business assets €na of Ultra Scientific by Agilent 2018-05-30
Aldeyra Therapeutics–Centogene: genomic services, 201805– collab identification of genetic markers for Sjögren-Larsson Syndrome using CentoMD 2018-05-29
Celgene–Evotec: drug discovery services, 201805– strategic RnD collab expansion $6m to incl additional cell lines 2018-05-29
High-Tech Gründerfonds–Bayer: investment, 201805 Bayer invests in HTGF III 2018-05-29
High-Tech Gründerfonds–Boehringer: investment, 201805 BIVF invests in HTGF III 2018-05-29
High-Tech Gründerfonds–SEVERAL: investment, 201805 2nd closing of HTGF III €71.5m bringing total fund size to €316.5m 2018-05-29
Treeway–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-29
Lunaphore–Vitro (ES): in situ hybridisation, 201805– collab developm ISH protocols for RNA + DNA targets in tissue 2018-05-24
Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors 2018-05-24
Evotec–I’rom Group: iPSC technology, 201805– license non-excl for iPSCs produced with Sendai virus vector technology from ID Pharma 2018-05-23
Lava Therapeutics–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-23
Orphazyme–Centogene: biomarker discovery, 201805– collab service biomarkers for Gaucher disease clinical trial monitoring 2018-05-23
Samsung–Sphingotec: investment, 201805 acquisition of Nexus Dx Inc from Samsung via joint venture with CEO Nam Shin 2018-05-22
Celgene–Evotec: drug discovery services, 201805– strategic RnD collab $65m upfront for cancer drugs 2018-05-21
Pierre Fabre–Roche: companion diagnostics, 201805– collab extension for developm of IHC CDx assay for ADC W0101 2018-05-18
Acousia Therapeutics–Boehringer: investment, 201805 financing round Series B totalling €10m incl existing + co-investor BIVF 2018-05-14
Acousia Therapeutics–Bregua Corp: investment, 201805 financing round Series B totalling €10m incl new + co-investor Bregua Corp 2018-05-14
Acousia Therapeutics–Creathor Ventures: investment, 201805 financing round Series B totalling €10m incl new + co-investor Creathor Venture 2018-05-14
Acousia Therapeutics–Germany (govt): investment, 201805 financing round Series B totalling €10m incl existing + co-investor KfW 2018-05-14
Acousia Therapeutics–Instinctif Partners: public relations, 201805 service existent by Instinctif 2018-05-14
Acousia Therapeutics–LBBW: investment, 201805 financing round Series B totalling €10m incl lead + new investor LBBW Venture Capital 2018-05-14
Acousia Therapeutics–SEVERAL: investment, 201805 financing round Series B €10m led by new investor LBBW Venture Capital 2018-05-14
Bluebird Bio–Medigene: TCR technology, 201805– collab strategic alliance expansion incl $8m one-time payment 2018-05-14
Polyneuron–SEVERAL: investment, 201805 seed financing round CHF3.1m led by EVA Basel + incl Zürcher Kantonalbank + private investors 2018-05-14
Valerius Biopharma–Catalent: contract manufacturing, 201805– collab cell line developm + manufacturing of speciality biosimilars using GPEx technology 2018-05-14
Armo BioSciences–Lilly: investment, 201805– acquisition $1.6b cash tender offer at $50/share by Eli Lilly 2018-05-10
Memo Therapeutics–Redalpine: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor Redalpine Venture Partners 2018-05-09
Memo Therapeutics–Schroders: investment, 201805 financing round Series A2 totalling CHF5m incl new investor Schroder Adveq 2018-05-09
Memo Therapeutics–SEVERAL: investment, 201805 financing round Series A2 CHF5m incl Schroder Adveq + investiere.ch + Redalpine Ventures et al. 2018-05-09
Memo Therapeutics–Verve Capital Partners: investment, 201805 financing round Series A2 totalling CHF5m incl new investor investiere.ch 2018-05-09
Memo Therapeutics–Zürcher Kantonalbank: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor ZKB 2018-05-09
PHAST–Eurofins: investment, 201805 acquisition of PHAST GmbH by Eurofins Scientific 2018-05-09
Bruker–CMS: legal services, 201805 service legal advice by CMS on acquisition of Sierra Sensors GmbH by Bruker 2018-05-06
Bruker–CMS: legal services, 201808 service legal advice by CMS on majority acquisition of Hain Lifescience by Bruker 2018-05-06
InflaRx–LifeSci: public relations, 201805 service existent IR by LifeSci Advisors + Media US by LifeSci Public Relations 2018-05-03
SmartDyeLivery–SEVERAL: investment, 201805 financing round from new investor STIFT + existing investors bm|t + Sparkasse Jena-Saale-Holzland 2018-05-03
Unisensor (BE)–Scienion: print/spotting technology, 201805 collab use of sciFlexarrayer techn for Extenso milk analysis platform 2018-05-03
Evotec–ERS Genomics: CRISPR technology, 201804– license €na to expand Evotec’s CRISPR-based service offering from ERS Genomics Ltd 2018-05-02
Genohm–Agilent: investment, 201805 acquisition €na of Genohm by Agilent 2018-05-02
InflaRx–SEVERAL: investment, 201805 primary public offering $51m+$7.65m w 1.5m+225k common shares at $34/share 2018-05-02
AdvanceCor–SEVERAL: investment, 201805 financing round €6m led by MIG AG + incl Occident Group + Bayern Kapital + HTGF + KfW Bank + founders 2018-05-01
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
NovellusDx–SEVERAL: investment, 201804 financing round $6m incl investors Helsinn + BCIF + Windham Venture Partners 2018-04-30
Roche–4D Molecular Therapeutics: gene delivery technology, 201804– collab expansion to develop + commercialise ophthalmic gene therapy products 2018-04-30
Roivant–SEVERAL: investment, 201804 financing round $40.5m of Datavant led by Roivant Sciences + Travis May 2018-04-30
Universal Patient Key–Roivant: investment, 201804 acquisition of UPK by Datavant 2018-04-30
Curetis–Global Corporate Finance: investment, 201804–202103 equity facility $10m solely at Curetis request up to 36 months at pre-agreed floor pricing 2018-04-27
Curetis–SEVERAL: investment, 201804 capital increase €4.1m offering of 854k new ordinary shares at €4.8/share to qualified EU + US investors 2018-04-27
Polyphor–Consilium: public relations, 201804 service existent international media relations by CSC 2018-04-27
Corvidia Therapeutics–SEVERAL: investment, 201804 financing round Series B $60m led by Venrock 2018-04-25
Boehringer–Topas Therapeutics: immuno modulatory compounds, 201804– collab €na multi-y research + option agreem 2018-04-24
Freenome–Biognosys: proteomic technology, 201804– collab enhancing circulating NA cancer test with proteomics data 2018-04-24
Revolution Medicines–Nextech: investment, 201804 financing round Series B totalling $56m incl lead investor Nextech Invest 2018-04-24
Revolution Medicines–SEVERAL: investment, 201804 financing round Series B $56m led by Nextech Invest 2018-04-24
Bosch–Randox: point-of-care diagnostics, –201804 collab developm test panels for Vivalytic POC analyser 2018-04-21
Merck (DE)–P&G: investment, 201804 acquisition €3.4b in cash of Merck’s consumer healthcare by P&G 2018-04-19
AiCuris–Max Planck: anti-infectives, 2018004– collab discovery of antibiotics + virostatic compounds extending existent collab with MPI-MP 2018-04-18
InterAx Biotech–LeadXPro: cancer immunotherapy, 201804– collab €na drug discovery + optimisation of lead molecules targeting GPCRs 2018-04-18
Novartis–Pear Therapeutics: digital health, 201804– collab developm + commercialisation of prescripition digital therapeutics for drug abuse Sandoz 2018-04-18
Tizona Therapeutics–Minapharm: biopharma production, 201804– supply service cell line + process developm + production of therap antibody by ProBioGen 2018-04-18
Anasys Instruments–Bruker: investment, 201804 acquisition of Anasys by Bruker 2018-04-17
DiaMan–GlucoMe: digital health, 201804– collab product integration of GlucoMe + DiaMan products + marketing in Central America by DiaMan 2018-04-17
DKSH–Bruker: analytical instruments, 201804– distribution multi-product line of Bruker AXS in KR + AU + NZ + SG + ID by DKSH Technology 2018-04-17
Biovertis–Deinove: investment, 201804–201805 acquisition of Biovertis/Morphochem for €900k in 500k new shares + 8m warrants 2018-04-13
Enterprise Therapeutics–Novartis: investment, 201804 financing round Series B totalling £29m ($41m) incl co-lead investor Novartis Venture Fund 2018-04-12
Enterprise Therapeutics–SEVERAL: investment, 201804 financing round Series B £29m ($41m) co-led by Versant Ventures + NVF 2018-04-12
Knauer–Microsaic: mass spectrometry, 201804– collab integration of Microsaic’s compact MS techn in Knauer’s LC platform 2018-04-12
Shire–Takeda: investment, 201804–201901 acquisition $62.2b (incl debt approx $80b) for $30.33 per share in cash + 0.839 Takeda shares per share 2018-04-12
Petra Pharma–Evotec: drug development services, 201804– supply service €na support developm of Petra-01 through to IND 2018-04-11
Roivant–Arbutus Biopharma: RNA drugs, 201804– collab founding of jv Genevant Sciences to develop RNA drugs using LNP technology 2018-04-11
Baliopharm–Promethera: investment, 201804 acquisition €na of Baliopharm AG by Promethera Biosciences SA 2018-04-10
Boehringer–Biomax: bioinformatics, 201804– license multi-year for BioXM s/w + license extension for BioRS s/w 2018-04-10
Promethera–MacDougall Biomedical Communications: public relations, 201804 service existent by MacDougall 2018-04-10
AveXis–Novartis: investment, 201804–201805 acquisition $8.7b in cash of AveXis Inc by Novartis for $128/share 2018-04-09
Grünenthal–Univ Leuven: pain drugs, 201804– collab r+d non-opioid pain drugs with CD3 + LICR 2018-04-09
Polyphor–SEVERAL: investment, 201804–201805 IPO CHF155m (€130m) at SIX Swiss Exchange at CHF38/share 2018-04-09
Rebiotix–Ferring: investment, 201804 acquisition of Rebiotix by Ferring 2018-04-05
Arvinas–Nextech: investment, 201804 financing round Series C totalling $55m incl new + lead investor Nextech Invest 2018-04-04
next pagenext page 1 2 3 ... 16 17 18 ... 30 31 32  next pagenext page



Advertisement

Picture [iito] Männer Ballett 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] No Content Marketing 650x80px

» top